Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Rodman & Renshaw analyst Brandon Folkes initiated coverage on Adial Pharmaceuticals, Inc. ADIL with a Buy rating and announced a price target of $8. Adial Pharmaceuticals shares closed at $0.9910 on Wednesday. See how other analysts view this stock.
- Truist Securities analyst Keith Hughes initiated coverage on Carlisle Companies Incorporated CSL with a Hold rating and announced a price target of $460. Carlisle shares closed at $454.83 on Wednesday. See how other analysts view this stock.
- Rodman & Renshaw analyst Brandon Folkes initiated coverage on Achieve Life Sciences, Inc ACHV with a Buy rating and announced a price target of $12. Achieve Life Sciences shares closed at $4.53 on Wednesday. See how other analysts view this stock.
- Oppenheimer analyst Ian Zaffino initiated coverage on Turning Point Brands, Inc. TPB with an Outperform rating and announced a price target of $65. Turning Point Brands shares closed at $55.00 on Wednesday. See how other analysts view this stock.
- Rodman & Renshaw analyst Brandon Folkes initiated coverage on Rockwell Medical, Inc. RMTI with a Buy rating and announced a price target of $5. Rockwell Medical shares closed at $2.63 on Wednesday. See how other analysts view this stock.
Considering buying TPB stock? Here’s what analysts think:
Read More:
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
